Janux Therapeutics, Inc. (JANX)

JANX is trading below its short-term averages and under the classic pivot around 18.20, signaling near-term pressure while longer-term averages remain supportive, producing a mixed profile. Momentum indicators lean bearish—ten-day momentum is negative and RSI sits in the low 40s—while MACD is neutral. ADX in the upper-20s indicates a moderately persistent trend to the downside, and ATR near 4.6% implies moderate volatility. On-balance volume is flagged as positive in the data, but short-term price action and the cluster of short moving averages below the pivot favor selling pressure. Technical takeaway: Sell bias driven by weak short-term price action and negative momentum.